Comments
Loading...

Haemonetics

HAENYSE
Logo brought to you by Benzinga Data
$75.49
-0.89-1.17%
At Close: -
$75.49
00.00%
After Hours: 5:19 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$125.00
Lowest Price Target1
$60.00
Consensus Price Target1
$101.27

Haemonetics (NYSE:HAE) Stock, Analyst Ratings, Price Targets, Forecasts

Haemonetics Corp has a consensus price target of $101.27 based on the ratings of 11 analysts. The high is $125 issued by JMP Securities on August 13, 2024. The low is $60 issued by Morgan Stanley on January 7, 2022. The 3 most-recent analyst ratings were released by Barrington Research, CL King, and B of A Securities on September 23, 2024, September 13, 2024, and September 11, 2024, respectively. With an average price target of $103 between Barrington Research, CL King, and B of A Securities, there's an implied 36.44% upside for Haemonetics Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
1
May
0
0
0
0
Jun
1
1
Aug
1
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barrington Research
CL King
B of A Securities
BTIG
Citigroup

1calculated from analyst ratings

Analyst Ratings for Haemonetics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Haemonetics (HAE) stock?

A

The latest price target for Haemonetics (NYSE:HAE) was reported by Barrington Research on September 23, 2024. The analyst firm set a price target for $108.00 expecting HAE to rise to within 12 months (a possible 43.07% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Haemonetics (HAE)?

A

The latest analyst rating for Haemonetics (NYSE:HAE) was provided by Barrington Research, and Haemonetics maintained their outperform rating.

Q

When was the last upgrade for Haemonetics (HAE)?

A

The last upgrade for Haemonetics Corp happened on June 12, 2024 when Needham raised their price target to $112. Needham previously had a hold for Haemonetics Corp.

Q

When was the last downgrade for Haemonetics (HAE)?

A

The last downgrade for Haemonetics Corp happened on January 27, 2022 when Needham changed their price target from N/A to N/A for Haemonetics Corp.

Q

When is the next analyst rating going to be posted or updated for Haemonetics (HAE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Haemonetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Haemonetics was filed on September 23, 2024 so you should expect the next rating to be made available sometime around September 23, 2025.

Q

Is the Analyst Rating Haemonetics (HAE) correct?

A

While ratings are subjective and will change, the latest Haemonetics (HAE) rating was a maintained with a price target of $108.00 to $108.00. The current price Haemonetics (HAE) is trading at is $75.49, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch